IPC to develop & revise IP general chapters, Monographs

Besides this, it also acts as a National Coordination Centre (NCC) for running the Pharmacovigilance Programme of India (PvPI).

337
IPC
IPC

Last Updated on October 10, 2024 by The Health Master

In a bid to improve drug quality standards, the Indian Pharmacopeia Commission (IPC) is reconstituting expert working groups (EWGs) to develop and revise general chapters and monographs of the Indian Pharmacopeia (IP). EWGs will also work toward international harmonization of pharmacopoeial texts.

IPC has invited applications from professionals and experts to join the EWGs of the IP. The last date for submitting the applications is February 28, 2022.

“This is a unique opportunity to share one’s information and experience with other subject experts and to better understand the process for development and revision of general chapters and monographs for the IP.

Becoming an expert also gives an opportunity to expand one’s knowledge of the IP and the Indian regulatory system,” IPC said in a statement.

The terms of reference for EWGs include the development and revision of general chapters and monographs allocated to the EWG by the IPC in the specified field, advising the IPC on questions received from the stakeholders related to the quality standards in IP and international harmonization of pharmacopoeial texts decided by the IP.

IPC has a mandate for publishing official drug standards in the IP at regular intervals. It publishes new editions, addendums of the IP as well as the National Formulary of India. It has a mandate for certification and distribution of IP reference substances.

Besides this, it also acts as a National Coordination Centre (NCC) for running the Pharmacovigilance Programme of India (PvPI).

Its mission is to promote public health and animal health in India by bringing out authoritative and officially accepted standards for quality of drugs including active pharmaceutical ingredients, excipients and dosage forms, used by health professionals, patients and consumers.

The work related to monograph development and their revision is carried out in consultation with various EWGs having members from drug regulatory authorities, drug testing laboratories, pharmaceutical and chemical industries, academia, and research organizations.

Members of the EWGs are appointed by the IPC for a defined period to deal with a specific aspect of the work or with a specific topic, and regular meetings of the EWGs are convened by the IPC to discuss IP related agendas.

Latest Circulars: (IPC) Indian Pharmacopoeia Commission

Latest Notifications regarding Pharmaceuticals

Latest on National Formulary of India (NFI)

NPPA extends trade margin capping on these 5 Medical Devices

Pharma Companies to pay $590 mn to US Native Americans over opioids

USFDA gives tentative nod to Alembic for Fesoterodine fumarate extended-release tablets

Freebies to doctors at your own cost, Pharma companies told

Panacea sells domestic formulation assets to Mankind Pharma

Pharma distributor among 3 held for illegal sale of Anesthetic drugs

IPC flags safety alert against most common Drug Ibuprofen – NSAID

Govt invites third round of applications under PLI Scheme for domestic API manufacturing

USFDA issues 3 observations to Granules Pharmaceuticals Inc

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news